Topic 9, • 1/29/25 2023-09-21-1 Topic 9 : Pharmacotherapy of PTSD, depression, and anxiety Previous 2023-09-21 Topic 8: FDA Communications, New Drug Approvals, New Indications, New Warnings Next 2023-09-21-2 Topic 9 : Pharmacotherapy of PTSD, depression, and anxiety You Might Also Like 2023-09-21-3 Topic 9 : Pharmacotherapy of PTSD, depression, and anxiety 2023-09-20 Topic 2: Polypharmacy in the Elderly 2023-09-21-2 Topic 9 : Pharmacotherapy of PTSD, depression, and anxiety 2023-09-20 Topic 5: Cardiovascular disease: HTN, Lipids, and Heart Failure, AFib and DOACs s 2023-09-20 Topic 4.: A Review of Current Guidelines for the Treatment of Obesity-Drugs.
Topic 9, • 1/29/25 2023-09-21-1 Topic 9 : Pharmacotherapy of PTSD, depression, and anxiety Previous 2023-09-21 Topic 8: FDA Communications, New Drug Approvals, New Indications, New Warnings Next 2023-09-21-2 Topic 9 : Pharmacotherapy of PTSD, depression, and anxiety You Might Also Like 2023-09-21-3 Topic 9 : Pharmacotherapy of PTSD, depression, and anxiety 2023-09-20 Topic 2: Polypharmacy in the Elderly 2023-09-21-2 Topic 9 : Pharmacotherapy of PTSD, depression, and anxiety 2023-09-20 Topic 5: Cardiovascular disease: HTN, Lipids, and Heart Failure, AFib and DOACs s 2023-09-20 Topic 4.: A Review of Current Guidelines for the Treatment of Obesity-Drugs.
